Compare NBHC & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBHC | CERT |
|---|---|---|
| Founded | 2009 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2012 | 2020 |
| Metric | NBHC | CERT |
|---|---|---|
| Price | $39.70 | $8.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $44.33 | $13.88 |
| AVG Volume (30 Days) | 308.4K | ★ 2.0M |
| Earning Date | 01-21-2026 | 11-06-2025 |
| Dividend Yield | ★ 3.11% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.15 | 0.07 |
| Revenue | $405,867,000.00 | ★ $415,551,000.00 |
| Revenue This Year | $8.48 | $10.82 |
| Revenue Next Year | $28.10 | $6.77 |
| P/E Ratio | ★ $12.67 | $126.84 |
| Revenue Growth | 1.03 | ★ 11.47 |
| 52 Week Low | $32.83 | $8.03 |
| 52 Week High | $47.11 | $15.69 |
| Indicator | NBHC | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 69.14 | 38.05 |
| Support Level | $38.45 | $8.95 |
| Resistance Level | $40.22 | $9.42 |
| Average True Range (ATR) | 0.72 | 0.38 |
| MACD | 0.27 | 0.08 |
| Stochastic Oscillator | 88.67 | 3.04 |
National Bank Holdings Corp is a bank holding company. It provides various banking products and financial services to commercial, business, and consumer clients in the United States. The company offers deposit products including checking accounts, savings accounts, money market accounts, and other deposit accounts, including fixed-rate and fixed-maturity time deposits. It also provides commercial and industrial loans and leases. In addition, it offers treasury management solutions comprising online and mobile banking, commercial credit cards, wire transfers, automated clearing house, and electronic bill payments.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.